Detailed Information on Publication Record
2020
Inaccuracy of Self-Completed COPD Assessment Test by Older Patients Leads to Underestimation of Disease Severity
KOBLIZEK, Vladimir, Vladimir ZINDR, Ondrej ZINDR, Stanislav HOLUB, Anna HRAZDIROVÁ et. al.Basic information
Original name
Inaccuracy of Self-Completed COPD Assessment Test by Older Patients Leads to Underestimation of Disease Severity
Authors
KOBLIZEK, Vladimir (203 Czech Republic, guarantor), Vladimir ZINDR (203 Czech Republic), Ondrej ZINDR (203 Czech Republic), Stanislav HOLUB (203 Czech Republic), Anna HRAZDIROVÁ (203 Czech Republic, belonging to the institution), Jana KOCIANOVA (203 Czech Republic), Michal SVOBODA (203 Czech Republic, belonging to the institution) and Petr DULICEK (203 Czech Republic)
Edition
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, NEW YORK, ELSEVIER SCIENCE INC, 2020, 1525-8610
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30227 Geriatrics and gerontology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.669
RIV identification code
RIV/00216224:14110/20:00115253
Organization unit
Faculty of Medicine
UT WoS
000504685400027
Keywords in English
Self-Completed COPD Assessment Test; Disease Severity
Tags
International impact, Reviewed
Změněno: 12/5/2021 12:52, Mgr. Tereza Miškechová
Abstract
V originále
Chronic obstructive pulmonary disease (COPD), a life-threatening condition, represents a considerable public health and socioeconomic challenge.1 Symptoms of this long-lasting respiratory disease can significantly impair patients' daily physical activities, reduce quality of life, and lead to excessive health care overuse. Modified Medical Research Council dyspnea scale is a basic tool for determining symptoms of dyspnea in COPD patients. However, because COPD subjects suffer from complex symptomatology, COPD Assessment Test (CAT), a validated patient-completed questionnaire, is now globally recommended as the first choice assessment tool to classify COPD individuals according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease, Inc) Strategy in daily practice.